Advanced search

Main

Healthcare, Pharmaceuticals & Biotechnology

Healthcare and drugs

Adhd Market: Pestel Analysis and Scenario Based Forecasts

Publications

Business, Finance & Insurance (35706)

Consumer Goods & Retail (127031)

Databases & Statistics (27)

Education & Consulting (0)

Industry (87698)

Healthcare, Pharmaceuticals & Biotechnology (58540)

Biotechnology (9100)

Pharmaceuticals (30490)

Healthcare and drugs (18950)

Services (0)

Government and Public Sector (553)

Technologies & Electronics (91477)

Company reports (70860)

Country reports (2187)

(Currently 512486 Items)

Partners

Healthcare and drugs / REPORT INFORMATION

Adhd Market: Pestel Analysis and Scenario Based Forecasts
Date	Jan, 2001
Pages	0
Price / format	€1669 / Hard Copy €1605 / Electronic €1605 / Site License

€1 605

Report Information | Custom-Tailored Research | Product Trade Lead

Abstract:
The slow advent of generic Adderall, due in part to the difficulty inestablishing bioequivalence, will allow the UK company the opportunity toswitch its patients to Adderall XRNew formulations, particularly of methylphenidate-based compounds are setto come to market in high numbers. This can be seen as an attempt toimprove the practicality of the drugs, and therefore the patient compliance

Table of contents:

EXECUTIVE SUMMARY

INTRODUCTION

ADHD OVERVIEW

Disease definition

Diagnostic criteria

American Academy of Pediatrics guidelines

Epidemiology

Prevalence

Prevalence forecasts

Etiology

Genetic predisposition

Neurotransmitter dysfunction

Comorbid disorders

Treatment

Pharmacotherapy

Non-drug treatment

CURRENT MARKET ANALYSIS

Global market

Leading drugs

Ritalin

Adderall

Concerta

Others

PIPELINE ANALYSIS

Unmet need in the pharmacological treatment of ADHD

Products in development

Clinical trial data

Novel formulations

PESTEL MARKET ANALYSIS

Political factors

American issues

Economic factors

Reimbursement of drugs

Price increases

Social factors

Acceptability of stimulant use

Abuse of treatment

Media involvement

Role of socioeconomic status

Technological factors

New patch formulation of Ritalin

New products in development

Environmental factors

Family environment

Educational environment

Medical environment

Legal factors

Patent expiries

Teacher responsibility for ensuring compliance

1990 Individuals with Disabilities Education Act (US)

Better Pharmaceuticals for Children Act

MARKET SCENARIOS

Market drivers

Market shares of the leading drugs

Backlash

The scenario

Market size in Backlash scenario

Acceptance

The scenario

Market size in Acceptance scenario

Steady growth

The scenario

Market size in Steady growth scenario

Summary of scenario forecasts

BIBLIOGRAPHY

Order this report

Product Trade Lead

0 leads found

Add New Buy/Sell Lead